Important therapeutic goals in chronic heart failure are to improve quality of life and to reduce the risk of hospitalization and mortality. According to current evidence, guideline-based therapy with the four drug groups ACE inhibitors/ARNIs, beta blockers, mineralocorticoid receptor antagonists and SGLT-2 inhibitors achieves the best effects. This has been proven in various studies.
This content is machine-translated. Please contact us if you need professional translation services.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Cardiac arrhythmias
Atrial fibrillation – what do current guidelines say?
- PANCREATIC CELLS
Exploration map
- DIABETES AND OBESITY
Influence of movement and muscle regulation
- New studies on COPD
From inhalers, allergies and physical activity
- Rare diseases
The Alagille syndrome
- The future is near or here?
Ablation for atrial fibrillation
- Interventional valve therapy
Gender differences
- Anemia